Literature DB >> 29488120

Are animals a source of Stenotrophomonas maltophilia in human infections? Contributions of a nationwide molecular study.

Aurélie Jayol1,2,3, Camille Corlouer1, Marisa Haenni4, Mélanie Darty5, Karine Maillard6, Marine Desroches1, Brigitte Lamy7,8, Estelle Jumas-Bilak9,10, Jean-Yves Madec4, Jean-Winoc Decousser11,12.   

Abstract

Stenotrophomonas maltophilia (Sm) is an archetypal environmental opportunistic bacterium responsible for health care-associated infections. The role of animals in human Sm infections is unknown. This study aims to reveal the genetic and phylogenetic relationships between pathogenic strains of Sm, both animal and human, and identify a putative role for animals as a reservoir in human infection. We phenotypically and genotypically characterized 61 Sm strains responsible for animal infections (mainly respiratory tract infections in horses) from a French nationwide veterinary laboratory network. We tested antimicrobial susceptibility and performed MLST and genogrouping using the concatenation of the seven housekeeping genes from the original MLST scheme. Excluding the eight untypeable strains owing to the lack of gene amplification, only 10 out of the 53 strains yielded a known ST (ST5, ST39, ST162, ST8, ST27, ST126, ST131). The genogroup distribution highlighted not only genogroups (genogroups 5 and 9) comprised exclusively of animal strains but also genogroups shared by human and animal strains. Interestingly, these shared genogroups were primarily groups 2 and 6, which have previously been identified as the two most frequent genogroups among human-pathogenic Sm strains, especially among respiratory pathogens. The antimicrobial susceptibility testing underlined the presence of acquired resistance: 18.8 and 7.5% of the tested isolates were resistant to the sulfonamide-trimethoprim combination and ciprofloxacin, respectively. Animal strains of Sm shared phylogenetic traits with some of the most successful human strains. The exact relationships between the human and animal strains, and the genetic support of these common traits, need to be determined.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29488120     DOI: 10.1007/s10096-018-3203-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  27 in total

1.  A USA300 variant and other human-related methicillin-resistant Staphylococcus aureus strains infecting cats and dogs in France.

Authors:  Marisa Haenni; Estelle Saras; Pierre Châtre; Christine Médaille; Michèle Bes; Jean-Yves Madec; Frédéric Laurent
Journal:  J Antimicrob Chemother       Date:  2011-12-06       Impact factor: 5.790

2.  Antimicrobial susceptibility and genetic relatedness of bovine Stenotrophomonas maltophilia isolates from a mastitis outbreak.

Authors:  M Ohnishi; T Sawada; K Marumo; K Harada; K Hirose; A Shimizu; M Hayashimoto; R Sato; N Uchida; H Kato
Journal:  Lett Appl Microbiol       Date:  2012-04-19       Impact factor: 2.858

3.  Variations in the sales and sales patterns of veterinary antimicrobial agents in 25 European countries.

Authors:  Kari Grave; Jordi Torren-Edo; Arno Muller; Christina Greko; Gerard Moulin; David Mackay
Journal:  J Antimicrob Chemother       Date:  2014-04-16       Impact factor: 5.790

4.  An outbreak of lymphadenitis associated with Stenotrophomonas (Xanthomonas) maltophilia in Omani goats.

Authors:  E H Johnson; R Al-Busaidy; M S Hameed
Journal:  J Vet Med B Infect Dis Vet Public Health       Date:  2003-03

5.  Characterization of blaCTX-M IncFII plasmids and clones of Escherichia coli from pets in France.

Authors:  Safia Dahmen; Marisa Haenni; Pierre Châtre; Jean-Yves Madec
Journal:  J Antimicrob Chemother       Date:  2013-07-12       Impact factor: 5.790

Review 6.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

Review 7.  An overview of various typing methods for clinical epidemiology of the emerging pathogen Stenotrophomonas maltophilia.

Authors:  Giovanni Gherardi; Roberta Creti; Arianna Pompilio; Giovanni Di Bonaventura
Journal:  Diagn Microbiol Infect Dis       Date:  2014-11-15       Impact factor: 2.803

8.  Genotyping of environmental and clinical Stenotrophomonas maltophilia isolates and their pathogenic potential.

Authors:  Martina Adamek; Jörg Overhage; Stephan Bathe; Josef Winter; Reinhard Fischer; Thomas Schwartz
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

9.  Expression of Sme efflux pumps and multilocus sequence typing in clinical isolates of Stenotrophomonas maltophilia.

Authors:  Hye Hyun Cho; Ji Youn Sung; Kye Chul Kwon; Sun Hoe Koo
Journal:  Ann Lab Med       Date:  2011-12-20       Impact factor: 3.464

10.  Phylogenetic analysis of Stenotrophomonas spp. isolates contributes to the identification of nosocomial and community-acquired infections.

Authors:  Vinicius Godoy Cerezer; Silvia Yumi Bando; Jacyr Pasternak; Marcia Regina Franzolin; Carlos Alberto Moreira-Filho
Journal:  Biomed Res Int       Date:  2014-04-10       Impact factor: 3.411

View more
  4 in total

Review 1.  Clinical challenges treating Stenotrophomonas maltophilia infections: an update.

Authors:  Maria F Mojica; Romney Humphries; John J Lipuma; Amy J Mathers; Gauri G Rao; Samuel A Shelburne; Derrick E Fouts; David Van Duin; Robert A Bonomo
Journal:  JAC Antimicrob Resist       Date:  2022-05-05

2.  Characterisation of Bacteriophage vB_SmaM_Ps15 Infective to Stenotrophomonas maltophilia Clinical Ocular Isolates.

Authors:  Dragica Damnjanović; Xabier Vázquez-Campos; Lisa Elliott; Mark Willcox; Wallace J Bridge
Journal:  Viruses       Date:  2022-03-29       Impact factor: 5.818

3.  Population Structure, Molecular Epidemiology, and β-Lactamase Diversity among Stenotrophomonas maltophilia Isolates in the United States.

Authors:  Maria F Mojica; Joseph D Rutter; Magdalena Taracila; Luciano A Abriata; Derrick E Fouts; Krisztina M Papp-Wallace; Thomas J Walsh; John J LiPuma; Alejandro J Vila; Robert A Bonomo
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

4.  Advances in the Microbiology of Stenotrophomonas maltophilia.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2021-05-26       Impact factor: 50.129

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.